A recent study published in the Canadian Journal of Microbiology demonstrates that the cannabis compound cannabidiol (CBD) may effectively inhibit the growth of Candida albicans, a yeast commonly associated with infections such as oral candidiasis.
Researchers treated C. albicans with varying concentrations of CBD, ranging from 0 to 20 µg/mL, and observed a significant reduction in yeast growth.
After one exposure to 20 µg/mL of CBD, the yeast cell count decreased from 5.1 × 10⁶ cell/mL in the control group to 1.8 × 10⁶ cell/mL. A second exposure further reduced the cell count to 1.1 × 10⁶ cell/mL. The study also noted a decrease in the yeast’s ability to transition from yeast to hyphae, a key factor in infection development, dropping from 20% in the control group to just 2% with CBD treatment.
Continue reading